The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Daratumumab, pomalidomide, and dexamethasone in relapsed refractory multiple myeloma (RRMM): A comparison with contemporary clinical trials.
 
Barry Paul
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Abbvie; Regeneron
Speakers' Bureau - Amgen
 
Myra M. Robinson
No Relationships to Disclose
 
Jordan Robinson
Speakers' Bureau - Sanofi
 
Ami Ndiaye
No Relationships to Disclose
 
Manisha Bhutani
Speakers' Bureau - Amgen
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Celularity (Inst); Janssen Research & Development (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - Genzyme
 
Peter Michael Voorhees
Honoraria - Oncopeptides
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; Karyopharm Therapeutics; Oncopeptides; Secura Bio
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline
 
James Thomas Symanowski
Consulting or Advisory Role - CARsgen Therapeutics; Endocyte (Inst); Immatics; Lilly
 
Reed N. Friend
Speakers' Bureau - Takeda
 
Mauricio Pineda-Roman
No Relationships to Disclose
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Sanofi; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics
 
Shebli Atrash
Honoraria - Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Speakers' Bureau - Celgene; Janssen
Research Funding - Amgen; GlaxoSmithKline; Karyopharm Therapeutics